Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 19 mrt 2013 - 08:00
Statutaire naam Esperite N.V.
Titel Cryo-Save Group N.V.: 2012 results impacted by non-recurring impairments, restructuring costs and the implementation of cost saving programs
Bericht Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, has published its financial results for the year ended 31 December 2012. The results during 2012 have been impacted by the economic headwind, especially in Southern Europe and by the effect of certain non-recurring costs as a result of restructuring and implementation of cost saving programs, which amounted to €16.2 million, of which €15.1 million were non-cash. This negatively affected the 2012 financial results.